These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27424177)

  • 21. Naphtho[1,2-b]furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: involvement of EGF receptor/PI3K/Akt signaling pathway.
    Chien CM; Lin KL; Su JC; Chuang PW; Tseng CH; Chen YL; Chang LS; Lin SR
    Eur J Pharmacol; 2010 Jun; 636(1-3):52-8. PubMed ID: 20371243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
    Fujii K; Furukawa F; Matsuyoshi N
    Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invadopodia formation in oral squamous cell carcinoma: the role of epidermal growth factor receptor signalling.
    Hwang YS; Park KK; Chung WY
    Arch Oral Biol; 2012 Apr; 57(4):335-43. PubMed ID: 21920495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
    Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
    Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells.
    Kuribayashi A; Kataoka K; Kurabayashi T; Miura M
    Endocrinology; 2004 Nov; 145(11):4976-84. PubMed ID: 15271882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lewisy promotes migration of oral cancer cells by glycosylation of epidermal growth factor receptor.
    Lin WL; Lin YS; Shi GY; Chang CF; Wu HL
    PLoS One; 2015; 10(3):e0120162. PubMed ID: 25799278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.
    Ohnishi Y; Yasui H; Kakudo K; Nozaki M
    Int J Oncol; 2015 Dec; 47(6):2165-72. PubMed ID: 26497980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties
    Hotta H; Hamamura K; Shibuya H; Ohmi Y; Furukawa K; Furukawa K
    Anticancer Res; 2021 Apr; 41(4):1821-1830. PubMed ID: 33813387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
    Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance of oral squamous cell carcinoma cells to cetuximab is associated with EGFR insensitivity and enhanced stem cell-like potency.
    Ohnishi Y; Minamino Y; Kakudo K; Nozaki M
    Oncol Rep; 2014 Aug; 32(2):780-6. PubMed ID: 24926885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD166 Engagement Augments Mouse and Human Hematopoietic Progenitor Function via Activation of Stemness and Cell Cycle Pathways.
    Zhang J; Ghosh J; Mohamad SF; Zhang C; Huang X; Capitano ML; Gunawan AM; Cooper S; Guo B; Cai Q; Broxmeyer HE; Srour EF
    Stem Cells; 2019 Oct; 37(10):1319-1330. PubMed ID: 31260147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum CD166: a novel hepatocellular carcinoma tumor marker.
    Ma L; Lin J; Qiao Y; Weng W; Liu W; Wang J; Sun F
    Clin Chim Acta; 2015 Feb; 441():156-62. PubMed ID: 25562819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
    Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.
    Ni C; Zhang Z; Zhu X; Liu Y; Qu D; Wu P; Huang J; Xu AX
    PLoS One; 2013; 8(8):e70958. PubMed ID: 23940674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
    Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
    J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.
    Zhang X; Jung IH; Hwang YS
    Tumour Biol; 2016 Feb; 37(2):2555-63. PubMed ID: 26386725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.